Stratasys (SSYS) Reports Q2: Everything You Need To Know Ahead Of Earnings

Stratasys (NASDAQ: SSYS) is set to report Q2 results Thursday before market open. The prior quarter revenue was $132.7 million, down 2.5% YoY, and it beat EPS estimates while full-year EBITDA guidance exceeded analysts’ expectations. For Q2, analysts expect flat revenue YoY. The article cites SSYS’s $12.33 average price target versus a $8.99 share price.

Original reporting
Published Aug 12, 2026, 4:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 4:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stratasys (SSYS) Reports Q2: Everything You Need To Know Ahead Of Earnings — source image
Decision brief

The 30-second read

$SSYSNeutralMed
01

Why it matters

The trading relevance comes from the earnings timing and the consensus expectation of flat YoY revenue, plus the note that analysts have reconfirmed estimates.

02

Market read

This is an earnings preview with consensus framing and peer read-through, not a new SSYS disclosure.

03

What to watch

The preview omits key earnings drivers (gross margin, operating expenses, backlog, guidance details), so traders may be underestimating what will actually move the stock.

Relevance 4/10Novelty 4/10Timing: pre-market this Thursday (earnings scheduled)

Background

The article frames Stratasys as reporting Q2 results this Thursday before market open, after a prior-quarter revenue beat and EPS beat.

Company-level read

Ticker impact

$SSYSNeutralMedium confidence
Context

Stratasys (SSYS) is set to report Q2 results this Thursday pre-market, with flat YoY revenue expected and prior-quarter beats noted.

Expected impact

Likely volatility around the pre-market earnings release, with direction dependent on whether revenue and guidance match the flat consensus framing.

Evidence & confidence

The text is primarily a preview: it cites expected flat YoY revenue, reconfirmed estimates, and that SSYS rarely misses revenue estimates, but does not disclose fresh guidance, filings, or a new catalyst.

Market effects

Industrial machinery and 3D printing sentiment is referenced as positive, but the article does not provide new sector data beyond peer earnings reactions.

No specific regional macro or demand signal is provided.

No global supply chain, regulation, or demand shock is mentioned.

Counterpoint

Even with a revenue beat history, the market may focus on margins, cash flow, or guidance quality, which the article does not quantify.

Key entities

  • Stratasys

    3D printing company scheduled to report Q2 results this Thursday before market open.

  • 3D Systems

    Peer cited as having posted flat YoY revenue and a modest beat, with shares up after results.

  • Proto Labs

    Peer cited as having revenue up 10.6% and a larger beat, with shares up after results.

Related articles

$SSYSHighAI 9/10

Stratasys To Buy Markforged For $42.5 Mln To Expand Defense, Aerospace Offering

Stratasys (SSYS) agreed to buy Markforged in an all-cash deal valued at $42.5 million to expand its defense and aerospace 3D-printing offerings, adding Markforged’s continuous carbon fiber technology and Digital Forge software. Stratasys expects margin and EBITDA accretion within one year after closing, with cost synergies, and will update guidance post-close. The deal is expected to close in H2 2026.

$IMNNMedAI 8/10

Imunon (IMNN) Q2 2026 Earnings Call Transcript

Imunon (IMNN) held its Q2 2026 earnings call. Management reported Phase 2 OVATION II median overall survival of 45.1 months vs 30.4 months, and PARP maintenance survival of 65.6 vs 41.4 months. Q2 R&D was $1.5M, G&A $1.3M, net loss $2.8M. Cash was $6.9M after a $10M financing.

$CRBGMed

Corebridge Financial (CRBG) Q2 2026 Earnings Call Transcript

Corebridge Financial (CRBG) reported Q2 2026 results on an earnings call. Adjusted pre-tax operating income was $664 million, down 21% year over year, while run-rate operating EPS rose 16% to $1.35. Core income sources were $1.6 billion. The company said it returned $412 million to shareholders and expects 2026 objectives and 2027 targets for the combined entity after its Equitable merger.

$ATECMed

Alphatec (ATEC) Q2 2026 Earnings Call Transcript

Alphatec Holdings (ATEC) reported Q2 2026 revenue of $214 million, up 15% year over year, with surgical revenue at $196 million, up 17%. Adjusted EBITDA rose 53% to $36 million, and GAAP gross margin was 72.2%. Management reaffirmed full-year revenue guidance near $882 million and raised adjusted EBITDA guidance to about $140 million.

$FTKHighAI 9/10

Flotek (FTK) Q2 2026 Earnings Call Transcript

Flotek Industries (FTK) held its Q2 2026 earnings call. Q2 revenue was $99.4 million, up 70% year over year, with adjusted EBITDA of $16.8 million. Net income rose to $10.0 million. The company raised 2026 guidance to $340 million to $350 million revenue and $47 million to $51 million adjusted EBITDA, citing Data Analytics growth and international chemistry sales, plus a 10-year Puerto Rico utilities contract.

$MBCMedAI 8/10

MasterBrand (MBC) Q2 2026 Earnings Call Transcript

MasterBrand (MBC) reported Q2 2026 results after completing its American Woodmark merger on May 28, 2026. Net sales were $815.2M, including $125.5M from Woodmark. Adjusted EBITDA was $62.5M. It guided H2 2026 net sales $2.05B to $2.11B and adjusted EBITDA $129M to $149M, while targeting net leverage below 2.0x by 2028.